pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
TRN-261
Pain
Tris Pharma Inc
0 catalysts
Preclinical
TRP-601
Hypoxic-Ischemic Encephalopathy
Chiesi Farmaceutici SpA
0 catalysts
TRULICITY
TRULICITY (DULAGLUTIDE)
1 INDICATIONS AND USAGE TRULICITY ® is indicated: As an adjunct to diet and e…
Glucagon-like peptide 1 receptor
$LLYELI LILLY & Co
0 catalysts
TRUQAP
← prev
page 167 of 271
next →
131
Pain89
Neurology1
TRUQAP (CAPIVASERTIB)
1 INDICATIONS AND USAGE TRUQAP, in combination with fulvestrant, is indicated…
Serine/threonine-protein kinase AKT
$AZNASTRAZENECA PLC
0 catalysts
TRUXIMA
TRUXIMA (RITUXIMAB-ABBS)
Celltrion Inc
0 catalysts
Phase 1
TRV-045
Diabetic Neuropathic Pain
Trevena Inc
0 catalysts
Phase 2
TRX-103
Crohn's Disease (Regional Enteritis)
Tr1X Inc
0 catalysts
Preclinical
TRX-105
Colitis
TaiRx Inc
0 catalysts
Phase 2
TRX-319
Primary Progressive Multiple Sclerosis (PPMS)
Tr1X Inc
0 catalysts
Phase 1
TRX-920
Unspecified Cancer
TaiRx Inc
0 catalysts
Phase 2
TSC-100
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$TCRXTScan Therapeutics, Inc.
0 catalysts
Phase 2
TSC-101
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$TCRXTScan Therapeutics, Inc.
0 catalysts
Phase 1
TSC-203 HLA-A*02:01
Head And Neck Cancer
$TCRXTScan Therapeutics, Inc.
0 catalysts
Phase 1
TSN-084
Triple-Negative Breast Cancer (TNBC)
Tyligand Biotechnology (Shanghai) Co Ltd
0 catalysts
Phase 2
TSN-1611
Solid Tumor
Tyligand Biotechnology (Shanghai) Co Ltd
0 catalysts
Phase 3
TSND-201
Post-Traumatic Stress Disorder (PTSD)
Transcend Therapeutics Inc
0 catalysts
Phase 2
TSRA-196
Alpha-1 Antitrypsin Deficiency (A1AD)
Tessera Therapeutics Inc
0 catalysts
Phase 2
TST-003
Metastatic Colorectal Cancer
Transcenta Holding Ltd
0 catalysts
Phase 1
TST-004
IgA Nephropathy (Berger's Disease)
Transcenta Holding Ltd
0 catalysts
Preclinical
TT-003
Hearing Disorders
Ting Therapeutics LLC
0 catalysts
Phase 1
TT-00920
Congestive Heart Failure (Heart Failure)
TransThera Sciences (Nanjing) Inc
0 catalysts
Phase 1
TT-01488
Diffuse Large B-Cell Lymphoma
TransThera Sciences (Nanjing) Inc
0 catalysts
Phase 1
TT-125
Non-Small Cell Lung Cancer
TOLREMO Therapeutics AG
0 catalysts
Preclinical
TT-20
Unspecified Neurologic Disorders
Tellus Therapeutics Inc
0 catalysts
Phase 3
TTAX-01
Diabetic Foot Ulcers
BioTissue Inc
0 catalysts
Phase 2
TTAX-03
Osteoarthritis Pain
BioTissue Inc
0 catalysts
Phase 1
TTC-352
Metastatic Breast Cancer
TTC Oncology LLC
0 catalysts
Phase 2
TTHX-1114
Fuchs Endothelial Corneal Dystrophy (FECD)
Trefoil Therapeutics LLC
0 catalysts
Phase 2
TTI-101
Metastatic Hepatocellular Carcinoma (HCC)
$TVRDTvardi Therapeutics, Inc.
0 catalysts
Phase 1
TTI-109
Fibrosis
$TVRDTvardi Therapeutics, Inc.
0 catalysts